Transcript MUSC Year in Review 2014

MUSC Health Year in Review
Great steps forward in 2014
Clinical Innovation
Sickle Cell Disease
Research
Evening the Odds for Sickle Cell Patients
Far fewer resources are available for sickle cell patients than for
patients with cancer
› Only one drug, hydroxurea, has been approved to treat these
patients
› Julie Kanter, MD, is leading numerous clinical trials of new drugs
› Excitement around a phase 1 trial of potentially curative gene
therapy
› New point-of-care blood test yields results within 15 minutes
› Test could prevent patients from being stigmatized
“We always have to be looking for new ways
to help patients.”
Dr. Julie Kanter, Director of Sickle Cell Disease Research, stops to talk with the
parent of a sickle cell patient.
Clinical innovation
MUSC Children’s Hospital
Heart Health Program
Heart Health: Small Steps Lead to Big
Change
Unhealthy diets and sedentary habits have left many children in
the US with diseases like hypertension and diabetes
Encouraging a healthier lifestyle in at-risk children is the goal of
the Heart Health Program
› Directed by Melissa H. Henshaw, MD
› Recognizes that behavior change does not occur overnight
› Provides children and their families consistent support
› Encourages children and families to take one step at a time
“Our bodies are very valuable and we need
to take care of them.”
Dietician Janet Carter provides nutrition and weight management counseling to
pediatric patients as part of the Heart Health Program. This service is now
available through MUSC Health’s Center for Telehealth.
Heart Health by the Numbers
6
5
4
Series 1
Series 2
Series 3
3
2
1
0
Category Category Category Category
1
2
3
4
According to September 2014 NRC data, MUSC Health’s cardiology program
has been showing improvement in the most key metrics.